Core Value & Strategy
Patient-centric
We focus on infectious diseases with high unmet needs because we believe no patients should be left behind.
Innovative thinking
We continuously iterate our process and innovate because we are dedicated to delivering the best therapies for our patients, in the most efficient way.
Diversity
We seek and welcome talent from all backgrounds and experience to create a dynamic and innovative work environment.
Operate with urgency
We operate efficiently to accelerate delivery of life-changing therapies to people impacted by significant unmet medical needs.
Team
“My strategy is to always ask this question:
How will the work or studies I am proposing support the next phase of the drug creation process?”
— Leen Kawas, PhD
Chief Executive Officer
Leen Kawas, Ph.D., PharmSci.
Chief Executive Officer
Xue Hua, PhD
Chief Development Officer
Mike Gibbs
Chief Commercial Officer
Ashwini Kadam, PhD
Executive Vice President, CMC
Vaishnavi Gandhe
Clinical
Heba Agha
Regulatory
Robert Taylor
Medical Affairs
April Leonard
Finance and Human Resources
Armaan Hirani
Data Science
Board of Directors
Jeffrey Glenn, MD, PhD
Co-founder of EIT Pharma, Inc., Director. Professor of Medicine at Stanford University
Leen Kawas, Ph.D., PharmSci.
Chief Executive Officer
Xue Hua, PhD
Chief Development Officer
Advisors
Jeffrey Glenn, MD, PhD
Co-founder of EIT Pharma, Inc., Director. Professor of Medicine at Stanford University
Ohad Etzion, MD
Director of the Department of Gastroenterology and Liver Diseases at Soroka University Medical Center
Edward A. Pham, MD
Instructor, Medicine - Gastroenterology & Hepatology at Stanford University